Medicare AdvantagePrior AuthMedium impact
Topical Vitamin D Products (Revised)
Humana·Dermatology, Family Medicine, General Practice +1 more·Medicare Advantage
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for topical vitamin D products (calcipotriene, calcipotriene-betamethasone, Taclonex) used for psoriasis treatment. Coverage requires documented diagnosis of plaque psoriasis and previous treatment/contraindication with high potency topical corticosteroids.
Action Required
Before January 1, 2026: Billing team must update prior authorization workflow for topical vitamin D products (calcipotriene, calcipotriene-betamethasone, Taclonex) for Humana Medicare Advantage patients. Providers must document plaque psoriasis diagnosis and previous treatment/contraindication with high potency topical corticosteroids before prescribing. Update EMR templates to include required criteria documentation. Claims without prior authorization will be denied.